Search results
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback
Investor's Business Daily· 1 year agoCatalyst Pharmaceuticals added a second product to its lineup Wednesday with a $160 million deal for...
Zacks.com featured highlights include Tsakos Energy, AVEO Pharmaceuticals and Catalyst...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – September 12, 2022 – Stocks in this week’s article are Tsakos...
Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, bluebird BLUE...
No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product
Investor's Business Daily· 1 year agoTeva Pharmaceutical said Monday it plans to knock off Catalyst Pharmaceuticals' only approved drug....
We Ran A Stock Scan For Earnings Growth And Catalyst Pharmaceuticals (NASDAQ:CPRX) Passed With Ease
Simply Wall St. via Yahoo Finance· 1 year agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera
Zacks via Yahoo Finance· 11 months agoCatalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North...
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 16, 2023 – Today, Zacks Investment Ideas feature...
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past...
Simply Wall St. via Yahoo Finance· 2 months agoThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if...
Catalyst Pharma, The No. 1 Tech Leader, Just Trounced Third-Quarter Expectations
Investor's Business Daily· 2 years agoCatalyst Pharmaceuticals trounced Wall Street's third-quarter forecasts and raised its full-year...
Stock Market Closes Higher As Weak Economic Data Fuels Rate Hopes; Tech-Heavy Nasdaq Leads
Investor's Business Daily· 1 year agoThe stock market closed higher Monday, led by the tech-heavy Nasdaq. A weaker-than-expected reading...